CAMBRIDGE COGNITION HOLDINGS PLC Logo

CAMBRIDGE COGNITION HOLDINGS PLC

Digital brain health assessment platform for CNS clinical trials and research.

COG | IL

Overview

Corporate Details

ISIN(s):
GB00B8DV9647 (+2 more)
LEI:
213800SZKDIN122EPA96
Country:
United Kingdom
Address:
TUNBRIDGE COURT, TUNBRIDGE LANE, BOTTISHAM, CB25 9TU CAMBRIDGE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cambridge Cognition Holdings PLC is a neuroscience technology company specializing in digital solutions for assessing brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, designed to accelerate drug development and enhance research. Its portfolio of technologies includes scientifically validated digital cognitive assessments (such as its flagship CANTAB® product), voice analysis, electronic questionnaires, and a comprehensive platform for decentralized clinical trials. With over 30 years of scientific validation, its highly sensitive tools enable precise measurement of cognitive changes in-clinic or at home. The company serves leading pharmaceutical organizations, academic research institutions, and healthcare professionals globally, with expertise across numerous therapeutic areas including Alzheimer's disease, depression, and schizophrenia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 08:35
Regulatory News Service
Change of Auditor
English 12.6 KB
2025-11-05 08:20
Board/Management Information
Board Updates
English 19.6 KB
2025-10-01 08:00
Share Issue/Capital Change
Block Listing Return
English 18.0 KB
2025-09-29 08:00
Declaration of Voting Results & Voting Rights Announcements
Exercise of Options and Total Voting Rights
English 13.9 KB
2025-09-26 10:59
Major Shareholding Notification
Holding(s) in Company
English 23.9 KB
2025-09-08 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-09-05 13:04
Major Shareholding Notification
Holding(s) in Company
English 52.9 KB
2025-09-02 18:21
Major Shareholding Notification
Holding(s) in Company
English 54.4 KB
2025-08-28 08:01
Board/Management Information
Changes to Board and Management
English 29.4 KB
2025-08-19 11:10
Regulatory News Service
Monument Therapeutics Partnership with FNIH
English 30.9 KB
2025-08-12 08:00
Earnings Release
Launch of Speaker Identification Solution
English 26.7 KB
2025-07-31 08:00
Earnings Release
Trading update for period ended 30 June 2025
English 22.4 KB
2025-06-27 13:27
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 31.6 KB
2025-06-04 08:00
Report Publication Announcement
Notice of AGM
English 14.4 KB
2025-05-06 18:59
Major Shareholding Notification
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE COGNITION HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE COGNITION HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE COGNITION HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sweden
MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden
ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.